Nimenrix Powder and Solvent for Solution for Injection Malezya - İngilizce - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

nimenrix powder and solvent for solution for injection

pfizer (malaysia) sdn. bhd. - meningococcus a, purified polysaccharides antigen; meningococcus w135, purified polysaccharides antigen; meningococcus y, purified polysaccharides antigen; meningococcus c, purified polysaccharides antigen conjugated -

MENQUADFI SOLUTION FOR INJECTION Singapur - İngilizce - HSA (Health Sciences Authority)

menquadfi solution for injection

sanofi-aventis singapore pte. ltd. - meningococcal polysaccharide, serogroup a (monovalent conjugate); meningococcal polysaccharide, serogroup c (monovalent conjugate); meningococcal polysaccharide, serogroup w-135 (monovalent conjugate); meningococcal polysaccharide, serogroup y (monovalent conjugate); tetanus toxoid, filtered concentrate (carrier protein) - injection, solution - meningococcal polysaccharide, serogroup a (monovalent conjugate) 10 mcg/ 0.5 ml; meningococcal polysaccharide, serogroup c (monovalent conjugate) 10 mcg/ 0.5 ml; meningococcal polysaccharide, serogroup w-135 (monovalent conjugate) 10 mcg / 0.5ml; meningococcal polysaccharide, serogroup y (monovalent conjugate) 10 mcg/ 0.5 ml; tetanus toxoid, filtered concentrate (carrier protein) 55 mcg/ 0.5 ml

MENQUADFI SOLUTION Kanada - İngilizce - Health Canada

menquadfi solution

sanofi pasteur limited - meningococcal group a polysaccharide-tetanus toxoid conjugate; meningococcal group c polysaccharide-tetanus toxoid conjugate; meningococcal group y polysaccharide-tetanus toxoid conjugate; meningococcal group w polysaccharide-tetanus toxoid conjugate; tetanus toxoid - solution - 10mcg; 10mcg; 10mcg; 10mcg; 55mcg - meningococcal group a polysaccharide-tetanus toxoid conjugate 10mcg; meningococcal group c polysaccharide-tetanus toxoid conjugate 10mcg; meningococcal group y polysaccharide-tetanus toxoid conjugate 10mcg; meningococcal group w polysaccharide-tetanus toxoid conjugate 10mcg; tetanus toxoid 55mcg - vaccines

MENACTRA İsrail - İngilizce - Ministry of Health

menactra

sanofi israel ltd - meningococcal vaccines group a; meningococcal vaccines group c; meningococcal vaccines group w; meningococcal vaccines group y - solution for injection - meningococcal vaccines group c 4 mcg / 0.5 ml; meningococcal vaccines group y 4 mcg / 0.5 ml; meningococcal vaccines group w 4 mcg / 0.5 ml; meningococcal vaccines group a 4 mcg / 0.5 ml - other meningococcal monovalent purified polysaccharides antigen - other meningococcal monovalent purified polysaccharides antigen - active immunization of individuals 9 months through 55 years of age for the prevention of invasive meningococcal disease caused by n meningitidis serogroups a, c, y, and w-135 menactra vaccine does not prevent n meningitidis serogroup b disease.

Menactra Avustralya - İngilizce - Department of Health (Therapeutic Goods Administration)

menactra

sanofi-aventis australia pty ltd - diphtheria toxoid; meningococcal polysaccharide - group w135; meningococcal polysaccharide - group a; meningococcal polysaccharide - group y; meningococcal polysaccharide - group c -

Menomune Avustralya - İngilizce - Department of Health (Therapeutic Goods Administration)

menomune

sanofi-aventis australia pty ltd - meningococcal polysaccharide - group a; meningococcal polysaccharide - group w135; meningococcal polysaccharide - group y; meningococcal polysaccharide - group c -

TRUMENBA (Meningococcal group B vaccine) suspension for injection pre-filled syringe Avustralya - İngilizce - Department of Health (Therapeutic Goods Administration)

trumenba (meningococcal group b vaccine) suspension for injection pre-filled syringe

pfizer australia pty ltd - neisseria meningitidis serogroup b recombinant lipidated- factor h binding protein subfamily a, quantity: 60 microgram; neisseria meningitidis serogroup b recombinant lipidated- factor h binding protein subfamily b, quantity: 60 microgram - injection, suspension - excipient ingredients: water for injections; aluminium phosphate; histidine; sodium chloride; polysorbate 80 - trumenba is indicated in individuals 10 years and older for active immunisation to prevent invasive meningococcal disease caused by neisseria meningitidis serogroup b.

MENOMUNE A/C/Y/W-135 (1 DOSE) Malezya - İngilizce - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

menomune a/c/y/w-135 (1 dose)

sanofi-aventis (malaysia) sdn. bhd. - neisseria meningitides,group w-135 polysaccaride; neisseria meningitides,group c polysaccharide; neisseria meningitides,group a polysaccharide; neisseria meningitides,group y polysaccharide -

MENACTRA SOLUTION Kanada - İngilizce - Health Canada

menactra solution

sanofi pasteur limited - meningococcal polysaccharide-diphtheria toxoid conjugate, group a; meningococcal polysaccharide-diphtheria toxoid conjugate, group c; meningococcal polysaccharide-diphtheria toxoid conjugate, group y; meningococcal polysaccharide-diphtheria toxoid conjugate, group w 135 - solution - 4.0mcg; 4.0mcg; 4.0mcg; 4.0mcg - meningococcal polysaccharide-diphtheria toxoid conjugate, group a 4.0mcg; meningococcal polysaccharide-diphtheria toxoid conjugate, group c 4.0mcg; meningococcal polysaccharide-diphtheria toxoid conjugate, group y 4.0mcg; meningococcal polysaccharide-diphtheria toxoid conjugate, group w 135 4.0mcg - vaccines